Introduction
Basal cell carcinoma (BCC) is the most common malignancy in Western populations. Metastatic BCC (mBCC), however, is extremely rare and occurs in only 0.0028%-0.55% of cases.
Despite the recent introduction of hedgehog pathway inhibitors, the prognosis for mBCC remains poor [1] .
Case Presentation
A 73-year-old previously healthy Caucasian woman was admitted to Uddevalla Hospital because of her impaired general condition. Her hemoglobin level was 40 g/L and she had experienced significant weight loss. Physical examination revealed a 37-× 14-cm ulcerated tumor from the cervical region vertebra C7 to the level of vertebrae L1-L2 ( Figure   1A ). The tumor had been growing on her back for the last decade. Biopsies of the tumor showed an infiltrative BCC.
Three firm subcutaneous nodules could be visualized and palpated along the in-transit route toward the right axilla with 2 nodules located 1 and 7 cm, respectively, from the ulcerated tumor and a third in the right axilla. 
